ABT vs IRT · P/E 25, rev $44.33B vs P/E 137, rev $332.6M
Abbott Laboratories (ABT) versus Independence Realty Trust Inc (IRT) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Independence Realty Trust Inc (IRT) is a reit - residential company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported IRT revenue for 2026-06-30 was $332.6M. Net income was $3.3M. IRT currently screens at market cap $4.26B and trailing P/E 136.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. IRT currently screens at market cap $4.26B and trailing P/E 136.8.
Not investment advice. Open the ABT and IRT stock pages for the full models.
Not investment advice.